Your Briefing on Newmont Stock

Newmont shares fell by -1.6% during the day's evening session, and are now trading at a price of $39.84. Is it time to buy the dip? To better answer that question, it's essential to check if the market is valuing the company's shares fairly in terms of its earnings and equity levels.

A Lower P/B Ratio Than Its Sector Average but Trades Above Its Graham Number:

Newmont Corporation engages in the production and exploration of gold. The company belongs to the Basic Materials sector, which has an average price to earnings (P/E) ratio of 10.03 and an average price to book (P/B) ratio of 2.08. In contrast, Newmont has a trailing 12 month P/E ratio of -56.9 and a P/B ratio of 1.64.

Newmont has moved -9.0% over the last year compared to 10.0% for the S&P 500 — a difference of -19.0%. Newmont has a 52 week high of $55.41 and a 52 week low of $37.45.

Increasing Revenues but Narrowing Margins:

2021-02-18 2022-02-24 2023-02-23
Revenue (MM) $11,497 $12,222 $11,915
Gross Margins 56.4% 55.5% 45.7%
Operating Margins 28.2% 16.3% 13.5%
Net Margins 24.61% 9.54% -3.6%
Net Income (MM) $2,829 $1,166 -$429
Net Interest Expense (MM) -$308 -$274 -$227
Depreciation & Amort. (MM) -$2,300 -$2,323 -$2,185
Earnings Per Share $3.51 $1.46 -$0.7
EPS Growth n/a -58.4% -147.95%
Diluted Shares (MM) 806 800 795
Free Cash Flow (MM) $6,184 $5,932 $5,351
Capital Expenditures (MM) -$1,302 -$1,653 -$2,131
Net Current Assets (MM) -$8,985 -$11,007 -$12,434
Current Ratio 2.52 2.9 2.23
Long Term Debt (MM) $7,038 $6,475 $6,399
Net Debt / EBITDA 0.46 0.63 2.37

Newmont has stable revenues and increasing reinvestment in the business, a steady stream of strong cash flows, and an excellent current ratio. The company also benefits from wider gross margins than its peer group, decent operating margins with a negative growth trend, and healthy leverage. However, the firm has declining EPS growth.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.